Details of Drug

Drug General Information (ID: D0176)
Drug Name	Betrixaban
Drug Type	Small molecule
Drug Synonymous	Betrixaban; 330942-05-7; Bevyxxa; PRT054021; UNII-74RWP7W0J9; PRT 054021; 74RWP7W0J9; betrixaban maleate; Betrixaban [USAN:INN]; betrixaban/; Betrixaban (USAN); D0J0BU; SCHEMBL158591; QCR-99; GTPL9602; EX-A358; MolPort-009-682-948; ZINC3 Click to Show/Hide
Disease Class	BD72: Venous thromboembolism; 8B1Z: Cerebral ischaemia
Therapeutic Class	Anticoagulants/Factor Xa Inhibitors
Structure
Structure	3D Structure		2D Structure
Formula	C23H22ClN5O3
InChI	1S/C23H22ClN5O3/c1-29(2)21(25)14-4-6-15(7-5-14)22(30)27-19-10-9-17(32-3)12-18(19)23(31)28-20-11-8-16(24)13-26-20/h4-13,25H,1-3H3,(H,27,30)(H,26,28,31)
InChIKey	XHOLNRLADUSQLD-UHFFFAOYSA-N
Canonical SMILES	CN(C)C(=N)C1=CC=C(C=C1)C(=O)NC2=C(C=C(C=C2)OC)C(=O)NC3=NC=C(C=C3)Cl
External Link
	Pubchem ID	10275777
	CAS Number	330942-05-7
	CHEBI ID	140421
	TTD ID	D0J0BU
	VARIDT ID	DR00216

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM002 Affected cellular transport AM006 Pharmacodynamic additive effects AM007 Pharmacodynamic antagonistic effects BM010 Transporter inhibition BM011 Transporter induction BM050 Increased risk of bleeding BM085 Antagonize the effect of antithrombotic agents BM107 Attenuated pharmacological effects (Unspecific)
Relation Graph

Full list of drugs interacting with Betrixaban
Affected cellular transport
	Transporter inhibition					Drug Num: 65
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0066		Amiodarone	C25H29I2NO3	2157	Major		Inter Info	[4], [5], [1]
D0139		Azithromycin	C38H72N2O12	447043	Major		Inter Info	[4], [5], [1]
D0170		Bepridil	C24H34N2O	2351	Major		Inter Info	[4], [5], [1]
D0267		Carvedilol	C24H26N2O4	2585	Major		Inter Info	[4], [5], [1]
D0349		Clarithromycin	C38H69NO13	84029	Major		Inter Info	[4], [5], [1]
D0402		Cyclosporine	C62H111N11O12	5284373	Major		Inter Info	[4], [5], [1]
D0497		Diltiazem	C22H26N2O4S	39186	Major		Inter Info	[4], [5], [1]
D0534		Dronedarone	C31H44N2O5S	208898	Major		Inter Info	[4], [5], [1]
D0597		Erythromycin	C37H67NO13	12560	Major		Inter Info	[4], [5], [1]
D0640		Felodipine	C18H19Cl2NO4	3333	Major		Inter Info	[4], [5], [1]
D0665		Flibanserin	C20H21F3N4O	6918248	Major		Inter Info	[4], [5], [1]
D0867		Itraconazole	C35H38Cl2N8O4	55283	Major		Inter Info	[4], [5], [1]
D0880		Ketoconazole	C26H28Cl2N4O4	456201	Major		Inter Info	[4], [5], [1]
D1119		Nelfinavir	C32H45N3O4S	64143	Major		Inter Info	[4], [5], [1]
D1353		Propafenone	C21H27NO3	4932	Major		Inter Info	[4], [5], [1]
D1371		Quinidine	C20H24N2O2	441074	Major		Inter Info	[4], [5], [1]
D1372		Quinine	C20H24N2O2	3034034	Major		Inter Info	[4], [5], [1]
D1383		Ranolazine	C24H33N3O4	56959	Major		Inter Info	[4], [5], [1]
D1415		Ritonavir	C37H48N6O5S2	392622	Major		Inter Info	[4], [5], [1]
D1423		Rolapitant	C25H26F6N2O2	10311306	Major		Inter Info	[4], [5], [1]
D1444		Saquinavir	C38H50N6O5	441243	Major		Inter Info	[4], [5], [1]
D1501		Spironolactone	C24H32O4S	5833	Major		Inter Info	[4], [5], [1]
D1526		Tacrolimus	C44H69NO12	445643	Major		Inter Info	[4], [5], [1]
D1687		Vemurafenib	C23H18ClF2N3O3S	42611257	Major		Inter Info	[4], [5], [1]
D1690		Verapamil	C27H38N2O4	2520	Major		Inter Info	[4], [5], [1]
D0044		Alpelisib	C19H22F3N5O2S	56649450	Moderate		Inter Info	[1]
D0099		Apremilast	C22H24N2O7S	11561674	Moderate		Inter Info	[1]
D0171		Berotralstat	C30H26F4N6O	137528262	Moderate		Inter Info	[1]
D0726		Glecaprevir	C38H46F4N6O9S	66828839	Moderate		Inter Info	[1]
D0192		Boceprevir	C27H45N5O5	10324367	Moderate		Inter Info	[1]
D0204		Brigatinib	C29H39ClN7O2P	68165256	Moderate		Inter Info	[1]
D0251		Capmatinib	C23H17FN6O	25145656	Moderate		Inter Info	[1]
D0254		Captopril	C9H15NO3S	44093	Moderate		Inter Info	[1]
D0375		Cobicistat	C40H53N7O5S2	25151504	Moderate		Inter Info	[1]
D0393		Crizotinib	C21H22Cl2FN5O	11626560	Moderate		Inter Info	[1]
D0408		Daclatasvir	C40H50N8O6	25154714	Moderate		Inter Info	[1]
D0555		Elagolix	C32H30F5N3O5	11250647	Moderate		Inter Info	[1]
D0556		Elbasvir	C49H55N9O7	71661251	Moderate		Inter Info	[1]
D0559		Eliglustat	C23H36N2O4	23652731	Moderate		Inter Info	[1]
D0569		Encorafenib	C22H27ClFN7O4S	50922675	Moderate		Inter Info	[6], [113]
D0590		Erdafitinib	C25H30N6O2	67462786	Moderate		Inter Info	[114]
D0632		Ezogabine	C16H18FN3O2	121892	Moderate		Inter Info	[1]
D0699		Fostamatinib	C23H26FN6O9P	11671467	Moderate		Inter Info	[115]
D0720		Gilteritinib	C29H44N8O3	49803313	Moderate		Inter Info	[1]
D0725		Glasdegib	C21H22N6O	25166913	Moderate		Inter Info	[1]
D0852		Isavuconazonium	C35H35F2N8O5S+	6918606	Moderate		Inter Info	[1]
D0866		Istradefylline	C20H24N4O4	5311037	Moderate		Inter Info	[1]
D0869		Ivacaftor	C24H28N2O3	16220172	Moderate		Inter Info	[1]
D0897		Lasmiditan	C19H18F3N3O2	11610526	Moderate		Inter Info	[154]
D0898		Ledipasvir	C49H54F2N8O6	67505836	Moderate		Inter Info	[1]
D0944		Lomitapide	C39H37F6N3O2	9853053	Moderate		Inter Info	[1]
D1062		Midostaurin	C35H30N4O4	9829523	Moderate		Inter Info	[1]
D1124		Neratinib	C30H29ClN6O3	9915743	Moderate		Inter Info	[1]
D1134		Nifedipine	C17H18N2O6	4485	Moderate		Inter Info	[1]
D1136		Nilotinib	C28H22F3N7O	644241	Moderate		Inter Info	[155]
D1315		Posaconazole	C37H42F2N8O4	468595	Moderate		Inter Info	[1]
D1393		Reserpine	C33H40N2O9	5770	Moderate		Inter Info	[1]
D1445		Sarecycline	C24H29N3O8	54681908	Moderate		Inter Info	[1]
D1471		Simeprevir	C38H47N5O7S2	24873435	Moderate		Inter Info	[1]
D1524		Suvorexant	C23H23ClN6O2	24965990	Moderate		Inter Info	[1]
D1541		Telaprevir	C36H53N7O6	3010818	Moderate		Inter Info	[1]
D1608		Tolvaptan	C26H25ClN2O3	216237	Moderate		Inter Info	[1]
D1660		Tucatinib	C26H24N8O2	51039094	Moderate		Inter Info	[1]
D1673		Valbenazine	C24H38N2O4	24795069	Moderate		Inter Info	[1]
D1686		Velpatasvir	C49H54N8O8	67683363	Moderate		Inter Info	[1]
	Transporter induction					Drug Num: 18
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0080		Amprenavir	C25H35N3O6S	65016	Moderate		Inter Info	[47], [48], [1]
D0095		Apalutamide	C21H15F4N5O2S	24872560	Moderate		Inter Info	[47], [1]
D0116		Atazanavir	C38H52N6O7	148192	Moderate		Inter Info	[47], [1]
D0255		Carbamazepine	C15H12N2O	2554	Moderate		Inter Info	[47], [1]
D0578		Enzalutamide	C21H16F4N4O2S	15951529	Moderate		Inter Info	[47], [1]
D0697		Fosphenytoin	C16H15N2O6P	56339	Moderate		Inter Info	[47], [1]
D0906		Letermovir	C29H28F4N4O4	45138674	Moderate		Inter Info	[47], [1]
D0953		Lorlatinib	C21H19FN6O2	71731823	Moderate		Inter Info	[47], [1]
D1081		Modafinil	C15H15NO2S	4236	Moderate		Inter Info	[47], [1]
D1198		Oxcarbazepine	C15H12N2O2	34312	Moderate		Inter Info	[47], [1]
D1265		Phenobarbital	C12H12N2O3	4763	Moderate		Inter Info	[47], [1]
D1283		Phenytoin	C15H12N2O2	1775	Moderate		Inter Info	[47], [1]
D1302		Pitolisant	C17H26ClNO	9948102	Moderate		Inter Info	[47], [1]
D1340		Primidone	C12H14N2O2	4909	Moderate		Inter Info	[47], [1]
D1399		Rifabutin	C46H62N4O11	135398743	Moderate		Inter Info	[47], [1]
D1400		Rifampicin	C43H58N4O12	135398735	Moderate		Inter Info	[47], [48], [1]
D1401		Rifapentine	C47H64N4O12	135403821	Moderate		Inter Info	[47], [1]
D1502		St. John's Wort	NA	NA	Moderate		Inter Info	[47], [1]
Pharmacodynamic additive effects
	Increased risk of bleeding					Drug Num: 146
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0005		Abciximab	NA	NA	Major		Inter Info	[1]
D0008		Acalabrutinib	C26H23N7O2	71226662	Major		Inter Info	[2]
D0017		Acetylsalicylic acid	C9H8O4	2244	Major		Inter Info	[3], [1]
D0047		Alteplase	NA	NA	Major		Inter Info	[1]
D0084		Anagrelide	C10H7Cl2N3O	135409400	Major		Inter Info	[1]
D0087		Anisindione	C16H12O3	2197	Major		Inter Info	[3], [1]
D0088		Anistreplase	NA	NA	Major		Inter Info	[3], [1]
D0092		Antithrombin Alfa	NA	NA	Major		Inter Info	[3], [1]
D0093		Antithrombin III human	NA	NA	Major		Inter Info	[3], [1]
D0096		Apixaban	C25H25N5O4	10182969	Major		Inter Info	[6], [7]
D0102		Ardeparin	C26H42N2O37S5	772	Major		Inter Info	[8], [9], [10]
D0104		Argatroban	C23H36N6O5S	92722	Major		Inter Info	[1]
D0129		Avapritinib	C26H27FN10	118023034	Major		Inter Info	[6], [11]
D0638		Fedratinib	C27H36N6O3S	16722836	Major		Inter Info	[1]
D0805		Inotersen	C230H318N69O121P19S19	121492004	Major		Inter Info	[6], [12], [13]
D1538		Tazemetostat	C34H44N4O4	66558664	Major		Inter Info	[3], [1]
D1718		Zanubrutinib	C27H29N5O3	135565884	Major		Inter Info	[12]
D0189		Bivalirudin	C98H138N24O33	16129704	Major		Inter Info	[1]
D0210		Bromfenac	C15H12BrNO3	60726	Major		Inter Info	[3], [1]
D0230		Cabozantinib	C28H24FN3O5	25102847	Major		Inter Info	[14]
D0247		Cangrelor	C17H25Cl2F3N5O12P3S2	9854012	Major		Inter Info	[3], [6], [15]
D0250		Caplacizumab	NA	NA	Major		Inter Info	[16], [6], [17]
D0336		Cilostazol	C20H27N5O2	2754	Major		Inter Info	[1]
D0364		Clopidogrel	C16H16ClNO2S	60606	Major		Inter Info	[1]
D0414		Dalteparin	C26H42N2O37S5	772	Major		Inter Info	[18], [19], [8], [20], [9], [10], [21]
D0415		Danaparoid	NA	NA	Major		Inter Info	[8], [9], [10]
D0428		Dasatinib	C22H26ClN7O2S	3062316	Major		Inter Info	[22]
D0432		Deferasirox	C21H15N3O4	214348	Major		Inter Info	[12], [23]
D0435		Defibrotide	C20H21N4O6P	135565962	Major		Inter Info	[6], [24]
D0447		Desirudin	C287H440N80O110S6	16129703	Major		Inter Info	[1]
D0462		Dextran (-1)	C18H32O16	4125253	Major		Inter Info	[3], [1]
D0463		Dextran (high molecular weight)	C18H32O16	4125253	Major		Inter Info	[3], [1]
D0464		Dextran (low molecular weight)	C18H32O16	4125253	Major		Inter Info	[3], [1]
D0476		Diclofenac	C14H11Cl2NO2	3033	Major		Inter Info	[1]
D0489		Diflunisal	C13H8F2O3	3059	Major		Inter Info	[1]
D0506		Dipyridamole	C24H40N8O4	3108	Major		Inter Info	[1]
D0537		Drotrecogin alfa	NA	NA	Major		Inter Info	[25]
D0551		Edoxaban	C24H30ClN7O4S	10280735	Major		Inter Info	[26]
D0574		Enoxaparin	C26H42N2O37S5	772	Major		Inter Info	[18], [19], [8], [20], [9], [10], [21]
D0586		Epoprostenol	C20H32O5	5282411	Major		Inter Info	[1]
D0588		Eptifibatide	C35H49N11O9S2	448812	Major		Inter Info	[1]
D0624		Etodolac	C17H21NO3	3308	Major		Inter Info	[1]
D0645		Fenoprofen	C15H14O3	3342	Major		Inter Info	[1]
D0680		Flurbiprofen	C15H13FO2	3394	Major		Inter Info	[1]
D0690		Fondaparinux	C31H53N3O49S8	5282448	Major		Inter Info	[18], [19], [8], [20], [9], [10], [21]
D0753		Heparin	C26H42N2O37S5	772	Major		Inter Info	[1]
D0784		Ibritumomab tiuxetan	NA	NA	Major		Inter Info	[27]
D0785		Ibrutinib	C25H24N6O2	24821094	Major		Inter Info	[28], [29], [6], [30]
D0786		Ibuprofen	C13H18O2	3672	Major		Inter Info	[1]
D0792		Iloprost	C22H32O4	5311181	Major		Inter Info	[1]
D0800		Indomethacin	C19H16ClNO4	3715	Major		Inter Info	[1]
D0841		Ipilimumab	NA	NA	Major		Inter Info	[3], [6], [31]
D0881		Ketoprofen	C16H14O3	3825	Major		Inter Info	[1]
D0882		Ketorolac	C15H13NO3	3826	Major		Inter Info	[1]
D0904		Lepirudin	C287H440N80O111S6	118856773	Major		Inter Info	[3], [1]
D0991		Mefenamic acid	C15H15NO2	4044	Major		Inter Info	[1]
D0995		Meloxicam	C14H13N3O4S2	54677470	Major		Inter Info	[1]
D1063		Mifepristone	C29H35NO2	55245	Major		Inter Info	[32], [33]
D1097		Nabumetone	C15H16O2	4409	Major		Inter Info	[1]
D1109		Naproxen	C14H14O3	156391	Major		Inter Info	[1]
D1174		Omacetaxine mepesuccinate	C29H39NO9	285033	Major		Inter Info	[12], [34]
D1196		Oxaprozin	C18H15NO3	4614	Major		Inter Info	[1]
D1221		Panobinostat	C21H23N3O2	6918837	Major		Inter Info	[16], [6], [35]
D1300		Piroxicam	C15H13N3O4S	54676228	Major		Inter Info	[1]
D1305		Plicamycin	C52H76O24	163659	Major		Inter Info	[3], [1]
D1313		Ponatinib	C29H27F3N6O	24826799	Major		Inter Info	[36]
D1328		Prasugrel	C20H20FNO3S	6918456	Major		Inter Info	[1]
D1380		Ramucirumab	NA	NA	Major		Inter Info	[37]
D1387		Regorafenib	C21H15ClF4N4O3	11167602	Major		Inter Info	[6], [38], [39]
D1395		Reteplase	NA	NA	Major		Inter Info	[1]
D1417		Rivaroxaban	C19H18ClN3O5S	9875401	Major		Inter Info	[40]
D1434		Ruxolitinib	C17H18N6	25126798	Major		Inter Info	[1]
D1506		Streptokinase	C11H19NO2	9815560	Major		Inter Info	[3], [1]
D1518		Sulfinpyrazone	C23H20N2O3S	5342	Major		Inter Info	[3], [1]
D1520		Sulindac	C20H17FO3S	1548887	Major		Inter Info	[1]
D1549		Temsirolimus	C56H87NO16	6918289	Major		Inter Info	[41]
D1550		Tenecteplase	NA	NA	Major		Inter Info	[1]
D1579		Ticagrelor	C23H28F2N6O4S	9871419	Major		Inter Info	[1]
D1581		Ticlopidine	C14H14ClNS	5472	Major		Inter Info	[3], [1]
D1588		Tinzaparin	C26H42N2O37S5	772	Major		Inter Info	[8], [9], [10]
D1592		Tipranavir	C31H33F3N2O5S	54682461	Major		Inter Info	[42]
D1593		Tirofiban	C22H36N2O5S	60947	Major		Inter Info	[1]
D1606		Tolmetin	C15H15NO3	5509	Major		Inter Info	[1]
D1613		Tositumomab	NA	NA	Major		Inter Info	[43], [44]
D1614		Tositumomab (I-131)	NA	NA	Major		Inter Info	[43], [44]
D1623		Trastuzumab emtansine	NA	NA	Major		Inter Info	[16], [6], [45]
D1625		Treprostinil	C23H34O5	6918140	Major		Inter Info	[1]
D1669		Urokinase	NA	NA	Major		Inter Info	[1]
D1705		Vorapaxar	C29H33FN2O4	10077130	Major		Inter Info	[46]
D1711		Warfarin	C19H16O4	54678486	Major		Inter Info	[1]
D0113		Asparaginase Erwinia chrysanthemi	NA	NA	Moderate		Inter Info	[49], [16], [6], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59]
D0114		Asparaginase Escherichia coli	NA	NA	Moderate		Inter Info	[49], [6], [50]
D0232		Calaspargase pegol	NA	NA	Moderate		Inter Info	[49], [6], [50]
D0331		Choline salicylate	C12H19NO4	54686350	Moderate		Inter Info	[60], [61], [62]
D0187		Bismuth subsalicylate	C7H6BiO4	16682734	Moderate		Inter Info	[64], [65], [60], [61], [66], [67], [68], [62]
D0211		Bromfenac (ophthalmic)	C15H12BrNO3	60726	Moderate		Inter Info	[69], [70], [71]
D0298		Celecoxib	C17H14F3N3O2S	2662	Moderate		Inter Info	[72]
D0345		Citalopram	C20H21FN2O	2771	Moderate		Inter Info	[73], [74], [75], [76], [16], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110]
D0361		Clomipramine	C19H23ClN2	2801	Moderate		Inter Info	[73], [74], [75], [76], [16], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110]
D0384		Collagenase clostridium histolyticum	NA	NA	Moderate		Inter Info	[111]
D1769		Deoxycholic acid	C24H40O4	222528	Moderate		Inter Info	[12], [112]
D0451		Desvenlafaxine	C16H25NO2	125017	Moderate		Inter Info	[73], [74], [75], [76], [16], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110]
D0457		Dexfenfluramine	C12H16F3N	66265	Moderate		Inter Info	[76], [105], [106]
D0477		Diclofenac (ophthalmic)	C14H11Cl2NO2	3033	Moderate		Inter Info	[69], [70], [71]
D0478		Diclofenac (topical)	C14H11Cl2NO2	3033	Moderate		Inter Info	[69], [70], [71]
D0539		Duloxetine	C18H19NOS	60835	Moderate		Inter Info	[73], [74], [75], [76], [16], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110]
D0599		Escitalopram	C20H21FN2O	146570	Moderate		Inter Info	[73], [74], [75], [76], [16], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110]
D0641		Fenfluramine	C12H16F3N	3337	Moderate		Inter Info	[73], [74], [75], [76], [16], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110]
D0676		Fluoxetine	C17H18F3NO	3386	Moderate		Inter Info	[73], [74], [75], [76], [16], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110]
D0681		Flurbiprofen (ophthalmic)	C15H13FO2	3394	Moderate		Inter Info	[69], [70], [71]
D0687		Fluvoxamine	C15H21F3N2O2	5324346	Moderate		Inter Info	[73], [74], [75], [76], [16], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110]
D0711		Garlic	NA	NA	Moderate		Inter Info	[116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130]
D0721		Ginger	C30H40O6	442138	Moderate		Inter Info	[121], [131], [132], [125], [128]
D0722		Ginkgo biloba	NA	NA	Moderate		Inter Info	[133], [134], [135], [136], [118], [137], [138], [119], [121], [122], [139], [131], [140], [125], [141], [142], [143], [128], [144]
D0723		Ginseng	C42H66O17	420552	Moderate		Inter Info	[145], [146], [147]
D0752		Hemin	C34H32FeN4O4	26945	Moderate		Inter Info	[148]
D1815		Icosapent	C20H30O2	446284	Moderate		Inter Info	[6], [149], [150]
D0883		Ketorolac (ophthalmic)	C15H13NO3	3826	Moderate		Inter Info	[69], [70], [71]
D0920		Levomilnacipran	C15H22N2O	6917779	Moderate		Inter Info	[73], [74], [75], [76], [16], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110]
D1066		Milnacipran	C15H22N2O	65833	Moderate		Inter Info	[73], [74], [75], [76], [16], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110]
D1123		Nepafenac (ophthalmic)	C15H14N2O2	151075	Moderate		Inter Info	[69], [70], [71]
D1139		Nintedanib	C31H33N5O4	135423438	Moderate		Inter Info	[156]
D1140		Niraparib	C19H20N4O	24958200	Moderate		Inter Info	[6], [157]
D1178		Omega-3 fatty acids	C60H92O6	56842239	Moderate		Inter Info	[6], [149], [150]
D1229		Paroxetine	C19H20FNO3	43815	Moderate		Inter Info	[73], [74], [75], [76], [16], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110]
D1234		Pegaspargase	C14H19NO	436058	Moderate		Inter Info	[49], [16], [6], [50], [51], [52], [53], [54], [55], [56], [57], [58], [59]
D1249		Pentosan polysulfate	C10H18O21S4	37720	Moderate		Inter Info	[12], [158]
D1251		Pentoxifylline	C13H18N4O3	4740	Moderate		Inter Info	[159], [160]
D1272		Phenyl salicylate	C13H10O3	8361	Moderate		Inter Info	[60], [61], [62]
D1421		Rofecoxib	C17H14O4S	5090	Moderate		Inter Info	[72]
D1439		Salicylic acid (sodium)	C7H6O3	338	Moderate		Inter Info	[60], [61], [62]
D1442		Salsalate	C14H10O5	5161	Moderate		Inter Info	[64], [65], [60], [61], [66], [67], [68], [62]
D1460		Selumetinib	C17H15BrClFN4O3	10127622	Moderate		Inter Info	[161], [162], [163]
D1461		Sertraline	C17H17Cl2N	68617	Moderate		Inter Info	[73], [74], [75], [76], [16], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110]
D1464		Sibutramine	C17H26ClN	5210	Moderate		Inter Info	[76], [105], [106]
D1894		Sugammadex	C72H112O48S8	6918585	Moderate		Inter Info	[6], [164]
D1522		Sunitinib	C22H27FN4O2	5329102	Moderate		Inter Info	[6], [165], [166]
D1674		Valdecoxib	C16H14N2O3S	119607	Moderate		Inter Info	[72]
D1689		Venlafaxine	C17H27NO2	5656	Moderate		Inter Info	[73], [74], [75], [76], [16], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110]
D1696		Vilazodone	C26H27N5O2	6918314	Moderate		Inter Info	[73], [74], [75], [76], [16], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110]
D1703		Vitamin E	C29H50O2	14985	Moderate		Inter Info	[161], [169], [6], [170], [171], [172], [173], [121], [174], [175], [176], [177], [178], [179], [180], [162], [181], [182], [163], [183]
D1708		Vortioxetine	C18H22N2S	9966051	Moderate		Inter Info	[73], [74], [75], [76], [16], [77], [78], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100], [101], [102], [103], [104], [105], [106], [107], [108], [109], [110]
D0309		Chamomile	C15H10O5	5280443	Minor		Inter Info	[146], [184], [125]
D1661		Turmeric	C21H20O6	969516	Minor		Inter Info	[185], [121], [186]
D0253		Capsicum	NA	NA	Minor		Inter Info	[146]
D0368		Clove	NA	NA	Minor		Inter Info	[121], [187], [188], [189]
Pharmacodynamic antagonistic effects
	Antagonize the effect of antithrombotic agents					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0373		Coagulation factor X human	NA	NA	Moderate		Inter Info	[63]
	Attenuated pharmacological effects (Unspecific)					Drug Num: 2
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1822		Iodide I-123	I-	135300	Moderate		Inter Info	[151], [152], [153]
D1691		Verteporfin	C82H84N8O16	11980904	Moderate		Inter Info	[167], [168]

References
1	Product Information. Bevyxxa (betrixaban). Portola Pharmaceuticals, South San Francisco, CA.
2	Product Information. Calquence (acalabrutinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
3	Bodiford AB, Kessler FO, Fermo JD, Ragucci KR "Elevated international normalized ratio with the consumption of grapefruit and use of warfarin." SAGE Open Med Case Rep 0 (2013): 1-3. [PMID: 27489634]
4	Bailey DG, Dresser GK "Natural products and adverse drug interactions." Can Med Assoc J 170 (2004): 1531-2. [PMID: 15136542]
5	Ho PC, Ghose K, Saville D, Wanwimolruk S "Effect of grapefruit juice on pharmacokinetics and pharmacodynamics of verapamil enantiomers in healthy volunteers." Eur J Clin Pharmacol 56 (2000): 693-8. [PMID: 11214778]
6	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
7	Product Information. Eliquis (apixaban). Bristol-Myers Squibb Canada Inc, Montreal, IN.
8	Product Information. Fragmin (dalteparin). Pharmacia and Upjohn, Kalamazoo, MI.
9	Product Information. Lovenox (enoxaparin). Rhone-Poulenc Rorer, Collegeville, PA.
10	Product Information. Normiflo (ardeparin). Wyeth-Ayerst Laboratories, Philadelphia, PA.
11	Product Information. Ayvakit (avapritinib). Blueprint Medicines Corporation, Cambridge, MA.
12	Product Information. Brukinsa (zanubrutinib). BeiGene USA, Inc, San Mateo, CA.
13	Product Information. Tegsedi (inotersen). Akcea Therapeutics, Cambridge, MA.
14	Product Information. Cometriq (cabozantinib). Exelixis Inc, S San Francisco, CA.
15	Product Information. Kengreal (cangrelor). The Medicines Company, Parsippany, NJ.
16	Cerner Multum, Inc. "Australian Product Information.".
17	Product Information. Cablivi (caplacizumab). Genzyme Corporation, Cambridge, MA.
18	Price AJ, Frcpath DO "Is there a clinical interaction between low molecular weight heparin and non-steroidal analgesics after total hip replacement?" Ann R Coll Surg Engl 77 (1995): 395. [PMID: 7486773]
19	Product Information. Arixtra (fondaparinux). Organon, West Orange, NJ.
20	Product Information. Innohep (tinzaparin) DuPont Pharmaceuticals, Wilmington, DE.
21	Product Information. Orgaran (danaparoid). Organon, West Orange, NJ.
22	Product Information. Sprycel (dasatinib). Bristol-Myers Squibb, Princeton, NJ.
23	Product Information. Exjade (deferasirox). Novartis Pharmaceuticals, East Hanover, NJ.
24	Product Information. Defitelio (defibrotide). Jazz Pharmaceuticals, Palo Alto, CA.
25	Product Information. Xigris (drotrecogin alfa). Lilly, Eli and Company, Indianapolis, IN.
26	Product Information. Savaysa (edoxaban). Daiichi Sankyo, Inc., Parsippany, NJ.
27	Product Information. In-111 Zevalin (ibritumomab). IDEC Pharmaceuticals Corporation, San Diego, CA.
28	Agencia Espaola de Medicamentos y Productos Sanitarios Healthcare "Centro de informacion online de medicamentos de la AEMPS - CIMA.".
29	Cerner Multum, Inc. "Canadian Product Information.".
30	Product Information. Imbruvica (ibrutinib). Pharmacyclics Inc, Sunnyvale, CA.
31	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports."
32	Product Information. Korlym (mifepristone). Corcept Therapeutics Incorporated, Menlo Park, CA.
33	Product Information. Mifeprex (mifepristone) Danco Laboratories, New York, NY.
34	Product Information. Synribo (omacetaxine). Teva Pharmaceuticals USA, North Wales, PA.
35	Product Information. Farydak (panobinostat). Novartis Pharmaceuticals, East Hanover, NJ.
36	Product Information. Iclusig (ponatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
37	Product Information. Cyramza (ramucirumab). Eli Lilly and Company, Indianapolis, IN.
38	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
39	Product Information. Stivarga (regorafenib). Bayer Pharmaceutical Inc, West Haven, CT.
40	Product Information. Xarelto (rivaroxaban). Bayer Inc, Toronto, IA.
41	Product Information. Torisel (temsirolimus). Wyeth-Ayerst Laboratories, Philadelphia, PA.
42	Product Information. Aptivus (tipranavir). Boehringer-Ingelheim, Ridgefield, CT.
43	Product Information. Bexxar I 131 Therapeutic (iodine I 131 tositumomab). GlaxoSmithKline, Research Triangle Park, NC.
44	Product Information. BexxarTherapy (tositumomab). GlaxoSmithKline Inc, Oakville, IA.
45	Product Information. Kadcyla (ado-trastuzumab). Genentech, South San Francisco, CA.
46	Product Information. Zontivity (vorapaxar). Merck & Company Inc, Whitehouse Station, NJ.
47	Gelosa P, Castiglioni L, Tenconi M, et.al "Pharmacokinetic drug interactions of the non-vitamin K antagonist oral anticoagulants (NOACs)" Pharmacol Res 135 (2018): 60-79. [PMID: 30040996]
48	Patel S, Robinson R, Burk M "Hypertensive crisis associated with St. John's Wort." Am J Med 112 (2002): 507-8. [PMID: 11959071]
49	Caruso V, Iacoviello L, Di Castelnuovo A, et.al "Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients." Blood 108 (2006): 2216-22. [PMID: 16804111]
50	Duarte X, Esteves S, Neto AM, Pereira F "Incidence and risk factors for central nervous system thrombosis in paediatric acute lymphoblastic leukaemia during intensive asparaginase treatment: a single-centre study." Br J Haematol 174 (2016): 280-91. [PMID: 27018199]
51	Elice F, Rodeghiero F "Hematologic malignancies and thrombosis." Thromb Res 129 (2012): 360-6. [PMID: 22197450]
52	Grace RF, DeAngelo DJ, Stevenson KE, et.al "The use of prophylactic anticoagulation during induction and consolidation chemotherapy in adults with acute lymphoblastic leukemia." J Thromb Thrombolysis 45 (2018): 306-14. [PMID: 29260426]
53	Kieslich M, Porto L, Lanfermann H, Jacobi G, Schwabe D, Bohles H "Cerebrovascular complications of L-asparaginase in the therapy of acute lymphoblastic leukemia." J Pediatr Hematol Oncol 25 (2003): 484-7. [PMID: 12794528]
54	Product Information. Asparlas (calaspargase pegol). Servier, Boston, MA.
55	Product Information. Elspar (asparaginase). Merck & Co, Inc, West Point, PA.
56	Product Information. Erwinaze (asparaginase Erwinia chrysanthemi). EUSA Pharma, Newtown, PA.
57	Product Information. Oncaspar (pegaspargase). Rhone-Poulenc Rorer, Collegeville, PA.
58	Truelove E, Fielding AK, Hunt BJ "The coagulopathy and thrombotic risk associated with L-asparaginase treatment in adults with acute lymphoblastic leukaemia." Leukemia 27 (2013): 553-9. [PMID: 23099335]
59	Mitchell L, Andrew M, Hanna K, et.al "Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study." Thromb Haemost 90 (2003): 235-44. [PMID: 12888870]
60	Fausa O "Salicylate-induced hypoprothrombinemia: a report of four cases." Acta Med Scand 188 (1970): 403-8. [PMID: 5490567]
61	Koch-Weser J, Sellers EM "Drug interactions with coumarin anticoagulants (first of two parts)." N Engl J Med 285 (1971): 487-98. [PMID: 4397794]
62	Wells PS, Holbrook AM, Crowther NR, Hirsh J "Interactions of warfarin with drugs and food." Ann Intern Med 121 (1994): 676-83. [PMID: 7944078]
63	Product Information. Coagadex (coagulation factor X). Bio Products Laboratory, Raleigh, NC.
64	Richards JR, Garber D, Laurin EG, et al. Treatment of cocaine cardiovascular toxicity: a systematic review.?Clin Toxicol (Phila). 2016;54(5):345-364. [PMID: 26919414]
65	Barrow MV, Quick DT, Cunningham RW "Salicylate hypoprothrombinemia in rheumatoid arthritis with liver disease. Report of two cases." Arch Intern Med 120 (1967): 620-4. [PMID: 6054600]
66	Koch-Weser J, Sellers EM "Drug interactions with coumarin anticoagulants (second of two parts)." N Engl J Med 285 (1971): 547-58. [PMID: 4397794]
67	Penning-van Beest F, Erkens J, Petersen KU, Koelz HR, Herings R "Main comedications associated with major bleeding during anticoagulant therapy with coumarins." Eur J Clin Pharmacol 61 (2005): 439-44. [PMID: 15947920]
68	Weiss HJ, Aledort LM, Kochwa S "The effect of salicylates on the hemostatic properties of platelets in man." J Clin Invest 47 (1968): 2169-80. [PMID: 5675432]
69	Product Information. Acular (ketorolac). Allergan Inc, Irvine, CA.
70	Product Information. Nevanac (nepafenac ophthalmic). Alcon Laboratories Inc, Fort Worth, TX.
71	Product Information. Xibrom (bromfenac ophthalmic). ISTA Pharmaceuticals, Irvine, CA.
72	Product Information. Celebrex (celecoxib). Searle, Chicago, IL.
73	Alderman CP, Moritz CK, Ben-Tovim DI "Abnormal platelet aggregation associated with fluoxetine therapy." Ann Pharmacother 26 (1992): 1517-9. [PMID: 1482806]
74	Alderman CP, Seshadri P, Ben-Tovim DI "Effects of serotonin reuptake inhibitors on hemostasis." Ann Pharmacother 30 (1996): 1232-4. [PMID: 8913401]
75	Aranth J, Lindberg C "Bleeding, a side effect of fluoxetine." Am J Psychiatry 149 (1992): 412. [PMID: 1536285]
76	Bannister SJ, Houser VP, Hulse JD, Kisicki JC, Rasmussen JG "Evaluation of the potential for interactions of paroxetine with diazepam, cimetidine, warfarin, and digoxin." Acta Psychiatr Scand Suppl 350 (1989): 102-6. [PMID: 2530759]
77	Ciraulo DA, Shader RI "Fluoxetine drug-drug interactions. II." J Clin Psychopharmacol 10 (1990): 213-7. [PMID: 2198298]
78	Claire RJ, Servis ME, Cram DL Jr "Potential interaction between warfarin sodium and fluoxetine." Am J Psychiatry 148 (1991): 1604. [PMID: 1928485]
79	Dalton SO, Johansen C, Mellemkjaer L, Norgard B, Sorensen HT, Olsen JH "Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study." Arch Intern Med 163 (2003): 59-64. [PMID: 12523917]
80	de Abajo FJ, Jick H, Derby L, Jick S, Schmitz S "Intracranial haemorrhage and use of selective serotonin reuptake inhibitors." Br J Clin Pharmacol 50 (2000): 43-7. [PMID: 10886117]
81	de Abajo FJ, Rodriguez LA, Montero D "Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study." BMJ 319 (1999): 1106-9. [PMID: 10531103]
82	de Maistre E, Allart C, Lecompte T, Bollaert PE "Severe bleeding associated with use of low molecular weight heparin and selective serotonin reuptake inhibitors." Am J Med 113 (2002): 530-2. [PMID: 12427509]
83	Dent LA, Orrock MW "Warfarin-fluoxetine and diazepam-fluoxetine interaction." Pharmacotherapy 17 (1997): 170-2. [PMID: 9017779]
84	Ford MA, Anderson ML, Rindone JP, Jaskar DW "Lack of effect of fluoxetine on the hypoprothrombinemic response of warfarin." J Clin Psychopharmacol 17 (1997): 110-2. [PMID: 10950474]
85	Hergovich N, Aigner M, Eichler HG, Entlicher J, Drucker C, Jilma B "Paroxetine decreases platelet serotonin storage and platelet function in human beings." Clin Pharmacol Ther 68 (2000): 435-42. [PMID: 11061584]
86	Humphries JE, Wheby MS, VandenBerg SR "Fluoxetine and the bleeding time." Arch Pathol Lab Med 114 (1990): 727-8. [PMID: 2363631]
87	Krivy J, Wiener J "Sertraline and platelet counts in idiopathic thrombocytopenia purpura." Lancet 345 (1995): 132. [PMID: 7815874]
88	Leung M, Shore R "Fluvoxamine-associated bleeding." Can J Psychiatry 41 (1996): 604-5. [PMID: 8946088]
89	Messiha FS "Fluoxetine - adverse effects and drug-drug interactions." J Toxicol Clin Toxicol 31 (1993): 603-30. [PMID: 8254702]
90	Ottervanger JP, Stricker BH, Huls J, Weeda JN "Bleeding attributed to the intake of paroxetine." Am J Psychiatry 151 (1994): 781-2. [PMID: 8166328]
91	Pai VB, Kelly MW "Bruising associated with the use of fluoxetine." Ann Pharmacother 30 (1996): 786-8. [PMID: 8826562]
92	Product Information. Brintellix (vortioxetine). Takeda Pharmaceuticals America, Lincolnshire, IL.
93	Product Information. Celexa (citalopram). Forest Pharmaceuticals, St. Louis, MO.
94	Product Information. Cymbalta (duloxetine). Lilly, Eli and Company, Indianapolis, IN.
95	Product Information. Effexor (venlafaxine). Wyeth-Ayerst Laboratories, Philadelphia, PA.
96	Product Information. Fetzima (levomilnacipran). Forest Pharmaceuticals, St. Louis, MO.
97	Product Information. Lexapro (escitalopram). Forest Pharmaceuticals, St. Louis, MO.
98	Product Information. Luvox (fluvoxamine). Solvay Pharmaceuticals Inc, Marietta, GA.
99	Product Information. Paxil (paroxetine). GlaxoSmithKline, Research Triangle Park, NC.
100	Product Information. Pristiq (desvenlafaxine). Wyeth Laboratories, Philadelphia, PA.
101	Product Information. Prozac (fluoxetine). Dista Products Company, Indianapolis, IN.
102	Product Information. Savella (milnacipran). Forest Pharmaceuticals, St. Louis, MO.
103	Product Information. Viibryd (vilazodone). Trovis Pharmaceuticals LLC, New Haven, CT.
104	Product Information. Zoloft (sertraline). Roerig Division, New York, NY.
105	Settle EC "Antidepressant drugs: disturbing and potentially dangerous adverse effects." J Clin Psychiatry 59 Suppl 16 (1998): 25-30. [PMID: 9796863]
106	Skop BP, Brown TM "Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors." Psychosomatics 37 (1996): 12-6. [PMID: 8600488]
107	Woolfrey S, Gammack NS, Dewar MS, Brown PJ "Fluoxetine-warfarin interaction." BMJ 307 (1993): 241. [PMID: 8369688]
108	Yaryura-Tobias JA, Kirschen H, Ninan P, Mosberg HJ "Fluoxetine and bleeding in obsessive-compulsive disorder." Am J Psychiatry 148 (1991): 949. [PMID: 2053641]
109	Layton D, Clark DWJ, Pearce GL, Shakir SAW "Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England." Eur J Clin Pharmacol 57 (2001): 167-76. [PMID: 11417450]
110	Tata LJ, Fortun PJ, Hubbard RB, et al. "Does concurrent prescription of selective serotonin reuptake inhibitors and non-steroidal anti-inflammatory drugs substantially increase the risk of upper gastrointestinal bleeding?" Aliment Pharmacol Ther 22 (2005): 175-81. [PMID: 16091054]
111	Product Information. Xiaflex (collagenase clostridium histolyticum). Auxilium Pharmaceuticals Inc, Norristown, PA.
112	Product Information. Kybella (deoxycholic acid). Kythera Biopharmaceuticals, Inc., Westlake Village, CA.
113	Product Information. Braftovi (encorafenib). Array BioPharma Inc., Boulder, CO.
114	Product Information. Balversa (erdafitinib). Janssen Products, LP, Horsham, PA.
115	Product Information. Tavalisse (fostamatinib). Rigel Pharmaceuticals, South San Francisco, CA.
116	Burnham BE "Garlic as a possible risk for postoperative bleeding." Plast Reconstr Surg 95 (1995): 213. [PMID: 7809259]
117	Chutani SK, Bordia A "The effect of fried versus raw garlic on fibrinolytic activity in man." Atherosclerosis 38 (1981): 417-21. [PMID: 7225179]
118	Evans V "Herbs and the brain: friend or foe? The effects of ginkgo and garlic on warfarin use." J Neurosci Nurs 32 (2000): 229-32. [PMID: 10994537]
119	Fugh-Berman A "Herb-drug interactions." Lancet 355 (2000): 134-8. [PMID: 10675182]
120	German K, Kumar U, Blackford HN "Garlic and the risk of TURP bleeding." Br J Urol 76 (1996): 518. [PMID: 7551902]
121	Heck AM, DeWitt BA, Lukes AL "Potential interactions between alternative therapies and warfarin." Am J Health Syst Pharm 57 (2000): 1221-7 quiz 1228-30. [PMID: 10902065]
122	Izzo AA, Ernst E "Interactions between herbal medicines and prescribed drugs: a systematic review." Drugs 61 (2001): 2163-75. [PMID: 11772128]
123	Kiesewetter H, Jung F, Jung EM, Mrowietz C, Kosciehlny J, Wenzel E "Effect of garlic on platelet aggregation in patients with increased risk of juvenile ischaemic attack." Eur J Clin Pharmacol 45 (1993): 333-6. [PMID: 8299665]
124	Legnani C, Frascaro M, Guazzaloca G, Ludovici S, Cesarano G, Coccheri S "Effects of a dried garlic preparation on fibrinolysis and platelet aggregation in healthy subjects." Arzneimittelforschung 43 (1993): 119-22. [PMID: 8457236]
125	Miller LG "Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions." Arch Intern Med 158 (1998): 2200-11. [PMID: 9818800]
126	Morris J, Burke V, Mori TA, Vandongen R, Beilin LJ "Effects of garlic extract on platelet aggregation: a randomized placebo-controlled double-blind study." Clin Exp Pharmacol Physiol 22 (1995): 414-7. [PMID: 8582091]
127	Steiner M, Lin RS "Changes in platelet function and susceptibility of lipoproteins to oxidation associated with administration of aged garlic extract." J Cardiovasc Pharmacol 31 (1998): 904-8. [PMID: 9641475]
128	Vaes LP, Chyka PA "Interactions of warfarin with garlic, ginger, or ginseng: nature of evidence." Ann Pharmacother 34 (2000): 1478-82. [PMID: 11144706]
129	Apitz-Castro R, Escalante J, Vargas R, Jain MK "Ajoene, the antiplatelet principle of garlic, synergistically potentiates the antiaggregatory action of prostacyclin, forskolin, indomethacin and dypiridamole on human platelets." Thromb Res 42 (1986): 303-11. [PMID: 3520940]
130	Mulrow C, Lawrence V, Ackermann R, et al. Garlic: effects on cardiovascular risks and disease, protective effects against cancer, and clinical adverse effects.?Evid Rep Technol Assess (Summ). 2000;(20):1-4. [PMID: 11089496]
131	Jiang X, Williams KM, Liauw WS, et al. "Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects." Br J Clin Pharmacol 59 (2005): 425-32. [PMID: 15801937]
132	Kruth P, Brosi E, Fux R, Morike K, Gleiter CH "Ginger-associated overanticoagulation by phenprocoumon." Ann Pharmacother 38 (2004): 257-60. [PMID: 14742762]
133	Benjamin J, Muir T, Briggs K, Pentland B "A case of cerebral haemorrhage - can Ginkgo biloba be implicated?." Postgrad Med J 77 (2001): 112-3. [PMID: 11161079]
134	Chung KF, McCusker M, Page CP, Dent G, Guinot P, Barnes PJ "Effect of ginkgolide mixture (BN 52063) in antagonising skin and platelet responses to platelet acitivating factor in man." Lancet 1 (1987): 248-51. [PMID: 2880069]
135	Cupp MJ "Herbal remedies: adverse effects and drug interactions." Am Fam Physician 59 (1999): 1239-45. [PMID: 10088878]
136	Engelsen J, Nielsen JD, Winther K "Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in stable, long-term warfarin treated outpatients. A randomised, double blind, placebo-crossover trial." Thromb Haemost 87 (2002): 1075-6. [PMID: 12083489]
137	Fessenden JM, Wittenborn W, Clarke L "Gingko biloba: A case report of herbal medicine and bleeding postoperatively from a laparoscopic cholecystectomy." Am Surg 67 (2001): 33-5. [PMID: 11206893]
138	Fong KC, Kinnear PE "Retrobulbar haemorrhage associated with chronic Gingko biloba ingestion." Postgrad Med J 79 (2003): 531-2. [PMID: 13679551]
139	Jayasekera N, Moghal A, Kashif F, Karalliedde L "Herbal medicines and postoperative haemorrhage." Anaesthesia 60 (2005): 725-6. [PMID: 15960738]
140	Matthews MK Jr "Association of Ginko biloba with intracerebral hemorrhage." Neurology 50 (1998): 1933-4. [PMID: 9633781]
141	Rosenblatt M, Mindel J "Spontaneous hyphema associated with ingestion of Ginkgo biloba extract." N Engl J Med 336 (1997): 1108. [PMID: 9091822]
142	Rowin J, Lewis SL "Spontaneous bilateral subdural hematomas associated with chronic Gingko biloba ingestion." Neurology 46 (1996): 1775-6. [PMID: 8649594]
143	Sierpina VS, Wollschlaeger B, Blumenthal M "Ginkgo biloba." Am Fam Physician 68 (2003): 923-6. [PMID: 13678141]
144	Wolf HR "Does Ginkgo biloba special extract EGb 761 provide additional effects on coagulation and bleeding when added to acetylsalicylic acid 500 mg daily?" Drugs R D 7 (2006): 163-72. [PMID: 16752942]
145	Ang-Lee MK, Moss J, Yuan CS "Herbal medicines and perioperative care." JAMA 286 (2001): 208-16. [PMID: 11448284]
146	Heck AM, DeWitt BA, Lukes AL "Potential interactions between alternative therapies and warfarin." Am J Health Syst Pharm 57 (2000): 1221-7 quiz 1228-30. [PMID: 10902065]
147	Hodges PJ, Kam PC "The peri-operative implications of herbal medicines." Anaesthesia 57 (2002): 889-99. [PMID: 12190754]
148	Product Information. Panhematin (hemin). Recordati Rare Diseases Inc, Lebanon, NJ.
149	Li XL, Steiner M "Fish oil: a potent inhibitor of platelet adhesiveness." Blood 76 (1990): 938-45. [PMID: 2118400]
150	Product Information. Vascepa (icosapent). Amarin Pharmaceuticals Inc, Warren, NJ.
151	Product Information. Rexulti (brexpiprazole). Otsuka American Pharmaceuticals Inc, Rockville, MD.
152	Warrington SJ, Ankier SI, Turner P "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology 15 (1986): 31-7. [PMID: 3725002]
153	Product Information. Sodium Iodide I-123 (sodium iodide I-123). GE Healthcare, Princeton, NJ.
154	Product Information. Reyvow (lasmiditan). Lilly, Eli and Company, Indianapolis, IN.
155	Product Information. Tasigna (nilotinib). Novartis Pharmaceuticals, East Hanover, NJ.
156	Product Information. Ofev (nintedanib). Boehringer Ingelheim, Ridgefield, CT.
157	Product Information. Zejula (niraparib). Tesaro Inc., Waltham, MA.
158	Product Information. Elmiron (pentosan polysulfate sodium). Baker Norton Pharmaceuticals, Miami, FL.
159	Canadian Pharmacists Association.
160	Product Information. Trental (pentoxifylline). Hoechst Marion-Roussel Inc, Kansas City, MO.
161	Booth SL, Golly I, Sacheck JM, Roubenoff R, Dallal GE, et al "Effect of vitamin E supplementation on vitamin K status in adults with normal coagulation status." Am J Clin Nutr 80 (2004): 143-8. [PMID: 15213041]
162	Murohara T, Ikeda H, Otsuka Y, Aoki M, Takajo Y, et al "Inhibition of platelet adherence to Mononuclear cells by alpha-tocopherol: role of P-selection." Circulation 110 (2004): 141-8. [PMID: 15197142]
163	Vitamin K, vitamin E and the coumarin drugs. Nutr Rev 40 (1982): 180-2. [PMID: 7121898]
164	Product Information. Bridion (sugammadex). Merck &amp Company Inc, Whitehouse Station, NJ.
165	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
166	Product Information. Sutent (sunitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
167	Product Information. Visudyne (verteporfin) Valeant Pharmaceuticals, Costa Mesa, CA.
168	Product Information. Xatral (alfuzosin). Sanofi-Synthelabo Canada Inc, Markham, ON.
169	Celestini A, Pulcinelli FM, Pignatelli P, et al. "Vitamin E potentiates the antiplatelet activity of aspirin in collagen-stimulated platelets." Haematologica 87 (2002): 420-6. [PMID: 11940487]
170	Corrigan JJ "The effect of vitamin E on warfarin-induced vitamin K deficiency." Ann N Y Acad Sci 393 (1982): 361-8. [PMID: 6959563]
171	Corrigan JJ, Ulfers LL "Effect of vitamin E on prothrombin levels in warfarin-induced vitamin K deficiency." Am J Clin Nutr 34 (1981): 1701-5. [PMID: 7282596]
172	Freedman JE, Farhat JH, Loscalzo J, Keaney JF "Alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C--dependent mechanism." Circulation 94 (1996): 2434-40. [PMID: 8921785]
173	Gonzalez-Correa JA, Arrebola MM, Guerrero A, et al. "Influence of vitamin E on the antiplatelet effect of acetylsalicylic acid in human blood." Platelets 16(3-4) (2005): 171-9. [PMID: 16011961]
174	Helson L "The effect of intravenous vitamin E and menadiol sodium diphosphate on vitamin K dependent clotting factors." Thromb Res 35 (1984): 11-8. [PMID: 6474408]
175	Jandak J, Steiner M, Richardson PD "Alpha-tocopherol, an effective inhibitor of platelet adhesion." Blood 73 (1989): 141-9. [PMID: 2910355]
176	Kakishita E, Suehiro A, Oura Y, Nagai K "Inhibitory effect of vitamin E (alpha-tocopherol) on spontaneous platelet aggregation in whole blood." Thromb Res 60 (1990): 489-99. [PMID: 2082481]
177	Kim JM, White RH "Effect of vitamin E on the anticoagulant response to warfarin." Am J Cardiol 77 (1996): 545-6. [PMID: 8629604]
178	Liu M, Wallmon A, Olsson-Mortlock C, Wallin R, Saldeen T "Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms." Am J Clin Nutr 77 (2003): 700-6. [PMID: 12600864]
179	Mardla V, Kobzar G, Samel N "Potentiation of antiaggregating effect of prostaglandins by alpha-tocopherol and quercetin." Platelets 15 (2004): 319-24. [PMID: 15370103]
180	Megavitamin E supplementation and vitamin K-dependent carboxylation. Nutr Rev 41 (1983): 268-70. [PMID: 6358960]
181	Schrogie JJ "Coagulopathy and fat-soluble vitamins." JAMA 232 (1975): 19. [PMID: 1172961]
182	Stampfer MJ, Jakubowski JA, Faigel D, Vaillancourt R, Deykin D "Vitamin E supplementation effect on human platelet function, arachidonic acid metabolism, and plasma prostacyclin levels." Am J Clin Nutr 47 (1988): 700-6. [PMID: 3128100]
183	Shalansky S, Lynd L, Richardson K, Ingaszewski A, Kerr C "Risk of warfarin-related bleeding events and supratherapeutic international normalized ratios associated with complementary and alternative medicine: a longitudinal analysis." Pharmacotherapy 27 (2007): 1237-47. [PMID: 17723077]
184	Lambert JP, Cormier J "Potential interaction between warfarin and boldo-fenugreek." Pharmacotherapy 21 (2001): 509-12. [PMID: 11310527]
185	Abebe W "Herbal medication: potential for adverse interactions with analgesic drugs." J Clin Pharm Ther 27 (2002): 391-401. [PMID: 12472978]
186	Yang X, Thomas DP, Zhang X, et al "Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation." Arterioscler Thromb Vasc Biol 26 (2006): 85-90. [PMID: 16239599]
187	Saeed SA, Gilani AH "Antithrombotic activity of clove oil." J Pak Med Assoc 44 (1994): 112-5. [PMID: 8078176]
188	Srivasta KC "Antiplatelet principles from a food spice clove (Syzygium aromaticum L) [corrected]" Prostaglandins Leukot Essent Fatty Acids 48 (1993): 363-72. [PMID: 8321872]
189	Srivstava KC, Malhotra N "Acetyl eugenol, a component of oil of cloves (Syzygium aromaticum L.) inhibits aggregation and alters arachidonic acid metabolism in human blood platelets." Prostaglandins Leukot Essent Fatty Acids 42 (1991): 73-81. [PMID: 2011614]

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence